Index

Show indicators by:

  • Cancer Control Domain
  • Disease Site
  • Dashboard
  • Cancer control domain
    • 1. Prevention
      • Smoking prevalence
      • Smoking behaviours in current cancer patients
      • Smoking cessation
      • Second-hand smoke exposure
      • Geographic variation in lung cancer risk
      • Alcohol consumption
      • Adult overweight and obesity
      • Active transportation
      • Physical inactivity
      • Human papillomavirus (HPV) vaccination
      • Fruit and vegetable consumption
      • Geographic variation in colorectal cancer risk
    • 2. Screening
      • Cervical cancer screening
      • Breast cancer screening
      • Colorectal cancer screening
      • PSA testing
      • Screening in underserved populations
    • 3. Diagnosis
      • Breast cancer diagnosis wait times
      • Colorectal cancer diagnosis wait times
      • Capture of stage
      • Stage distribution
      • Prostate risk profile
    • 4. Treatment
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
        • Breast cancer resections that are mastectomies
        • High-risk, resource-intensive surgeries for esophageal, pancreatic, liver, lung and ovarian cancers in Canada
        • Prostate wait times for surgery
        • Radical prostatectomy: open versus laparoscopic surgery
      • Radiation therapy
        • Radiation therapy wait times
        • Radiation therapy utilization and capacity
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
        • Post-operative radiation therapy for patients with stage I or II breast cancer
        • Prostate wait times for radiation therapy
        • Prostate patterns of care: radiation and surgical treatment
      • Systemic therapy
        • Post-operative chemotherapy for stage III colon cancer patients
        • Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer
    • 5. Person-Centred Perspective
      • Screening for distress
      • Patient satisfaction
      • Place of death
      • Prostate access to palliative radiation
    • 6. Research
      • Adult clinical trial participation
      • Prostate clinical trials participation
      • Pediatric clinical trial participation
      • Cancer research investment
      • Prostate cancer research investment
    • 7. Appropriateness
      • Breast cancer screening outside of guidelines
      • Breast cancer mastectomies done as day surgery
      • Intensive care use in the last two weeks of life
    • 8. Long-term outcomes
      • Breast cancer
      • Lung cancer
      • Colorectal cancer
      • Prostate cancer
      • Pancreatic cancer
      • Five-year net survival by income quintile for several cancers in Canada
  • Disease Site
    • Breast
      • Breast cancer screening
      • Screening in underserved populations
      • Breast cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Breast cancer resections that are mastectomies
        • The use of breast-conserving surgery versus mastectomies for breast cancer resections
      • Radiation therapy
        • Post-operative radiation therapy for stage I or II breast cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Breast cancer screening outside recommended guidelines
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Colorectal
      • Colorectal cancer screening
      • Geographic variation in colorectal cancer risk
      • Screening in underserved populations
      • Colorectal cancer diagnosis wait time
      • Capture of stage
      • Stage distribution
      • Surgery
        • Removal and examination of 12 or more lymph nodes in colon resections
        • Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non-small cell lung cancer patients
      • Radiation therapy
        • Pre-operative radiation therapy for patients with stage II or III rectal cancer
      • Post-operative chemotherapy for stage III colon cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Lung
      • Capture of stage
      • Stage distribution
      • Geographic variation in lung cancer risk
      • Resection rates for stage II or IIIA Non-snmall cell lung cancer patients
      • Post-operative chemotherapy for stage II or IIIA non-small cell lung cancer patients
      • Place of death
      • Adult clinical trial participation
      • Cancer research investment
      • Incidence and mortality rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Prostate
      • PSA testing
      • Prostate risk profile
      • Capture of stage
      • Stage distribution
      • Prostate wait times for surgery
      • Prostate wait times for radiation therapy
      • Radical prostatectomy: open versus laparoscopic surgery
      • Prostate patterns of care: radiation and surgical treatment
      • Prostate access to palliative radiation
      • Prostate clinical trials participation
      • Adult clinical trial participation
      • Prostate cancer research investment
      • Cancer research investment
      • Incidence & Mortality Rates
      • Five-year net survival by income quintile for several cancers in Canada
    • Cervical
      • Human papillomavirus (HPV) vaccination
      • Cervical cancer screening
      • Screening in underserved populations
    • Pancreas
      • Incidence and mortality rates
    • Stage Distribution
  • Province & Territory
System Performance Logo
System Performance
  • About
  • Reports
  • Home
  • Cancer control domain
  • 4. Treatment
  • Surgery
  • Prostate wait times for surgery

Prostate wait times for surgery

  • Charts and Tables

    Charts and Tables

    Figure 4.8

    Median and 90th percentile surgery wait times from booking date to surgery for prostate cancer, by province — 2014

    • Download & Export

      Figure

      •  

      Data Table

      • CSV
      • Excel
      • Json
      • XML

    "-" Data not available.

    AB: Includes biopsies as the sole procedures; includes patient unavailable days; includes neo-adjuvant therapy.

    SK: Includes radical prostatectomy cases only.

    ON: Includes endoscopic cases.

    QC: Start date is the date the surgeon signs the surgical request.

    PE: Includes emergency cases; includes days when the patient was unavailable.

    NL: Excludes suspected cases.

    Data source: Canadian Institute of Health Information (CIHI).

    Data Table

    ProvinceMedian wait time (days)90th Percentile wait time (days)
    BC2973
    AB3987
    SK43105
    MB--
    ON3685
    QC3485
    NB2659
    NS5674
    PE2794
    NL3264

    + Expand Table

    "-" Data not available.

    AB: Includes biopsies as the sole procedures; includes patient unavailable days; includes neo-adjuvant therapy.

    SK: Includes radical prostatectomy cases only.

    ON: Includes endoscopic cases.

    QC: Start date is the date the surgeon signs the surgical request.

    PE: Includes emergency cases; includes days when the patient was unavailable.

    NL: Excludes suspected cases.

    Data source: Canadian Institute of Health Information (CIHI).

  • Data specifications

    Data specifications

    Data and measurement considerations

    • The results presented here are based on data provided by the provinces to the Canadian Institute for Health Information (CIHI). The data include men 18 years and older with proven or suspected prostate cancer (new, recurrent, metastatic) who had surgery to treat or manage prostate cancer. It excludes patients who only had a biopsy, who only received neo-adjuvant therapy (i.e., given before the main treatment) and who were emergency cases.
    • The definition of prostate cancer cases, cancer surgeries and start date may vary across provinces. See figure footnotes and refer to CIHI’s Wait Times website (http://waittimes.cihi.ca/All/prostate) for more details.

    Wait times for surgery

    • Definition: Median and 90th percentile surgery wait times for prostate cancer (men aged 35 and older), measured in days
    • Measures: a. Median wait time (days); b. 90th percentile wait time (days)
    • Data source: Canadian Institute of Health Information (CIHI)
    • Measurement timeframe: 2014 treatment year
    • Stratification variables: Province
    • Provinces/territories with data available: BC, AB, SK, ON, QC, NB, NS, PE and NL
    • Province-specific notes: AB: Includes biopsies as the sole procedures; includes patient unavailable days; includes neo-adjuvant therapy. SK: Includes radical prostatectomy cases only. ON: Includes endoscopic cases. QC: Start date is the date the surgeon signs the surgical request. PE: Includes emergency cases; includes days when the patient was unavailable. NL: Excludes suspected cases.
  • Related indicators

    Related Indicators

    Prostate wait times for radiation therapy

    Median and 90th percentile radiation therapy wait times from ready-to-treat to start of radiation for prostate cancer, by province, by risk category — 2013 treatment year
    View this indicator
    Radical prostatectomy: open versus laparoscopic surgery

    Percentage of prostate cancer patients receiving radical prostatectomies, by surgical approach (%), by province — 2013-2014 combined
    View this indicator
    Prostate patterns of care: radiation and surgical treatment

    Percentage of low-risk prostate cancer patients (men aged ≥ 35) receiving various types of radiation therapy ,† by province — 2010 diagnosis year
    View this indicator
  • About Us
  • Careers
  • Contact
  • Media centre
  • Share your feedback
  • About our new site

  • Français Language toggle.

Other related sites:

  • Canadian Partnership for Tomorrow Project
  • Canadian Cancer Research Alliance
  • Canadian Cancer Trials
  • facebook
  • twitter
  • youtube
  • linkedin
    CPAC Logo

    Questions about cancer?

    For information about cancer treatment and support for patients, please contact the Canadian Cancer Society at 1-888-939-3333 or by completing this online form.

  • AODA compliance
  • Privacy policy
  • Terms of use
  • FAQ
  • Site map
  • About this site
© Canadian Partnership Against Cancer Corporation